BERK, V. Et Al. 2013. Predictive significance of VEGF and HIF-1? expression in metastatic colorectal cancer patients receiving chemotherapy combined with bevacizumab. 49th ASCO annual meeting .

BERK, V., DENİZ, K., KARACA, H., İNANÇ, M., BOZKURT, O., OCAK DURAN, A., ... ÖZKAN, M.(2013). Predictive significance of VEGF and HIF-1? expression in metastatic colorectal cancer patients receiving chemotherapy combined with bevacizumab . 49th ASCO annual meeting

BERK, VELİ Et Al. "Predictive significance of VEGF and HIF-1? expression in metastatic colorectal cancer patients receiving chemotherapy combined with bevacizumab," 49th ASCO annual meeting, 2013

BERK, VELİ Et Al. "Predictive significance of VEGF and HIF-1? expression in metastatic colorectal cancer patients receiving chemotherapy combined with bevacizumab." 49th ASCO annual meeting , 2013

BERK, V. Et Al. (2013) . "Predictive significance of VEGF and HIF-1? expression in metastatic colorectal cancer patients receiving chemotherapy combined with bevacizumab." 49th ASCO annual meeting .

@conferencepaper{conferencepaper, author={VELİ BERK Et Al. }, title={Predictive significance of VEGF and HIF-1? expression in metastatic colorectal cancer patients receiving chemotherapy combined with bevacizumab}, congress name={49th ASCO annual meeting}, city={}, country={}, year={2013}}